Professor of Radiation Oncology, University Wash
Radiology
Dr. Janet F. Eary, MD
|
|
Give Review
Janet Eary is an expert in the field of Radiology. She received 2 awards: "Regional Top Doctor" and "Super Doctor". Janet Eary has written publications. She has 51 publications published with PubMed. The lastest publication is: 'S0502: A SWOG Phase III Randomized Study of Imatinib, With or Without Bevacizumab, in Patients With Untreated Metastatic or Unresectable Gastrointestinal Stromal Tumors.'
Publications
- S0502: A SWOG Phase III Randomized Study of Imatinib, With or Without Bevacizumab, in Patients With Untreated Metastatic or Unresectable Gastrointestinal Stromal Tumors.
- Noninvasive Imaging of Experimental Lung Fibrosis.
- VOXEL-LEVEL MAPPING OF TRACER KINETICS IN PET STUDIES: A STATISTICAL APPROACH EMPHASIZING TISSUE LIFE TABLES.
- Activity of P-Glycoprotein, a β-Amyloid Transporter at the Blood-Brain Barrier, Is Compromised in Patients with Mild Alzheimer Disease.
- A Phase 2 Study of 16α-[(18)F]-fluoro-17β-estradiol Positron Emission Tomography (FES-PET) as a Marker of Hormone Sensitivity in Metastatic Breast Cancer (MBC).
- 131I Therapy Using rhTSH Stimulation and Dosimetry in Metastatic Malignant Struma Ovarii.
- Standards for Reporting PET Clinical Trials.
- Solitary fibrous tumor: WHO classification, histopathological correlation contribution to the radiology-pathology conference, FDG PET-CT imaging, and biological behavi...
- Impact of 18F-FDG PET/CT Imaging in Therapeutic Decisions for Malignant Solitary Fibrous Tumor of the Pelvis.
- NY-ESO-1 is a ubiquitous immunotherapeutic target antigen for patients with myxoid/round cell liposarcoma.
- Physical Activity Assessment in Adolescents with Limb Salvage.
- Sport Concussion Assessment Tool - 2: Baseline Values for High School Athletes.
- Imaging in Sarcoma.
- Multiagent PET for risk characterization in sarcoma.
- C11-acetate and F-18 FDG PET for men with prostate cancer bone metastases: relative findings and response to therapy.
- (18)F-FDG PET in sarcoma treatment response imaging.
- NCI-sponsored trial for the evaluation of safety and preliminary efficacy of 3'-deoxy-3'-[18F]fluorothymidine (FLT) as a marker of proliferation in patients with recur...
- Differential-absorption photoacoustic imaging.
- [F-18]-fluorodeoxy-D-glucose-positron emission tomography response is associated with outcome for extremity osteosarcoma in children and young adults.
- Risk assessment based on FDG-PET imaging in patients with synovial sarcoma.
- Spatial heterogeneity in sarcoma 18F-FDG uptake as a predictor of patient outcome.
- Proliferation imaging to measure early cancer response to targeted therapy.
- NCI-sponsored trial for the evaluation of safety and preliminary efficacy of FLT as a marker of proliferation in patients with recurrent gliomas: safety studies.
- PET imaging for Treatment Response in Cancer.
- Tumor-specific positron emission tomography imaging in patients: [18F] fluorodeoxyglucose and beyond.
- High-dose 131Itositumomab (anti-CD20) radioimmunotherapy and autologous hematopoietic stem-cell transplantation for adults > or = 60 years old with relapsed or refr...
- PET imaging: update on sarcomas.
- 131I-anti-CD45 antibody plus busulfan and cyclophosphamide before allogeneic hematopoietic cell transplantation for treatment of acute myeloid leukemia in first remiss...
- 166Ho-DOTMP radiation-absorbed dose estimation for skeletal targeted radiotherapy.
- [18F]Fluorodeoxyglucose positron emission tomography predicts outcome for Ewing sarcoma family of tumors.
- Evaluation of 18F-annexin V as a PET imaging agent in an animal model of apoptosis.
- Use of positron emission tomography in localized extremity soft tissue sarcoma treated with neoadjuvant chemotherapy.
- Comparison of different quantitative approaches to 18F-fluoride PET scans.
- High-dose (131)I-tositumomab (anti-CD20) radioimmunotherapy for non-Hodgkin's lymphoma: adjusting radiation absorbed dose to actual organ volumes.
- Positron emission tomography of schwannomas: emphasizing its potential in preoperative planning.
- Production of [F-18]fluoroannexin for imaging apoptosis with PET.
- Fluorodeoxyglucose positron emission tomography scanning: basic principles and imaging of adult soft-tissue sarcomas.
- High-dose radioimmunotherapy versus conventional high-dose therapy and autologous hematopoietic stem cell transplantation for relapsed follicular non-Hodgkin lymphoma:...
- PET imaging of osteosarcoma.
- Molecular (functional) imaging for radiotherapy applications: an RTOG symposium.
- High-dose 166Ho-DOTMP in myeloablative treatment of multiple myeloma: pharmacokinetics, biodistribution, and absorbed dose estimation.
- Molecular targeting of platelet-derived growth factor B by imatinib mesylate in a patient with metastatic dermatofibrosarcoma protuberans.
- Kinetic analysis of 2-[11C]thymidine PET imaging studies of malignant brain tumors: preliminary patient results.
- Kinetic analysis of 2-[11C]thymidine PET imaging studies of malignant brain tumors: compartmental model investigation and mathematical analysis.
- Evaluation of chemotherapy response in pediatric bone sarcomas by [F-18]-fluorodeoxy-D-glucose positron emission tomography.
- High-dose chemo-radioimmunotherapy with autologous stem cell support for relapsed mantle cell lymphoma.
- 2-[(18)F]Fluoro-2-deoxyglucose and glucose uptake in malignant gliomas before and after radiotherapy: correlation with outcome.
- Detection of locoregional and distant recurrences in breast cancer patients by using FDG PET.
- Positron Emission Tomography in Grading Soft Tissue Sarcomas.
- Tetramer guided, cell sorter assisted production of clinical grade autologous NY-ESO-1 specific CD8(+) T cells.
Schools
Michigan State University
University of Washington
Doctors Specialties
- Nuclear Medicine
- Radiology
Accepted Insurances
Awards
- Regional Top Doctor
- Super Doctor
Education
-
University of Washington -
Michigan State University College of Human Medicine
Hospital
-
Seattle Children's Hospital -
University of Washington Medical Center -
University of Alabama Hospital
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1942384565 |
| Last Name Of The Provider | EARY |
| First Name Of The Provider | JANET |
| View All |
Similar Doctors
|
|
Dr. Annie J. Chandrankunnel, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gerald P. Camren, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joseph G. Rajendran, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stephen I. Marglin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gregor M. Dunham, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Manuela C. Matesan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Sudhakar N. Pipavath, MB
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jennifer A. Westmoreland, MD
This Doctor is OpenDoctor Recommended.
|